Australia markets closed

Medibio Limited (MEB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
At close: 3:59PM AEST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2020
30/06/2019
30/06/2018
30/06/2017
Total revenue
141.834
133.5
364.628
204.878
23.1
Cost of revenue
237.014
204.688
226.092
75.669
-
Gross profit
-95.18
-71.188
138.536
129.209
23.1
Operating expenses
Research development
279.913
359.954
394.906
3,255
4,321
Selling general and administrative
1,500
2,449
6,684
10,013
3,131
Total operating expenses
2,941
4,360
9,938
18,817
12,675
Operating income or loss
-3,036
-4,431
-9,799
-18,688
-12,652
Interest expense
5.499
26.596
13.928
8.139
266.659
Total other income/expenses net
808.029
588.22
3,196
2,257
3,099
Income before tax
-2,225
-3,872
-6,587
-16,300
-9,785
Income tax expense
0
0
0
0
0
Income from continuing operations
-2,225
-3,872
-6,587
-16,300
-9,785
Net income
-2,225
-3,872
-6,587
-16,300
-9,785
Net income available to common shareholders
-2,225
-3,872
-6,587
-16,300
-9,785
Basic EPS
-
-0.00
-0.03
-0.08
-0.07
Diluted EPS
-
-0.00
-0.03
-0.08
-0.07
Basic average shares
-
880,092
226,026
203,871
124,342
Diluted average shares
-
880,092
226,026
203,871
124,342
EBITDA
-
-3,697
-9,799
-14,963
-7,792